pädiatrie
Erbliche Kryopyrin assoziierte periodische Syndrome (Kyopyrinopathien)
Literatur zur Behandlung
1.Lachmann HJ, Kone-Paut I, Kuemmerle-Deschner JB, et al: Use of canakinumab in the cryopyrin-associated periodic syndrome.N Engl J Med360(23):2416–2425, 2009. doi: 10.1056/NEJMoa0810787 2.Sibley CH, Plass N, Snow J, et al: Sustained response and prevention of damage progression in patients with neonatal-onset multisystem inflammatory disease treated with anakinra: A cohort study to determine three- and five-year outcomes.Arthritis Rheum64(7):2375–2386, 2012. doi: 10.1002/art.34409 3.Hoffman HM, Throne ML, Amar NJ, et al: Long-term efficacy and safety profile of rilonacept in the treatment of cryopyrin-associated periodic syndromes: Results of a 72-week open-label extension study.Clin Ther34(10):2091–2103, 2012. doi: 10.1016/j.clinthera.2012.09.009 